MEDP
Medpace Holdings, Inc.
Key Financials
Operating Income
$534.9M
↑ 19.7%
EPS (Diluted)
$15.28
↑ 21.0%
Net Income
$451.1M
↑ 11.6%
Total Liabilities
$1.5B
↑ 18.9%
Revenue
$2.5B
↑ 20.0%
Total Assets
$2.0B
↓ 6.0%
Cash & Equivalents
$497.0M
↓ 25.8%
Shareholders' Equity
$459.1M
↓ 44.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/19/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 4/28/2026 | View on SEC |
| 4 | 4/28/2026 | View on SEC |
| 4 | 4/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MEDP |
| Company Name | Medpace Holdings, Inc. |
| CIK | 1668397 |
| Sector | Services-Commercial Physical & Biological Research |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (513) 579-9911 |